Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Organogenesis Holdings Inc.ORGO · Entity 6275 | Director | March 09, 2026 | March 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Organogenesis Holdings Inc.
Report date March 09, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 291,014 |
Reported balance
After 2026-03-09 transaction · row 1
1 source rowRow 1 · 2026-03-09 · Purchase · Acquired 5,000 · Balance 291,014 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2026 Filed Mar 11, 2026 21:45 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 5,000 | $2.68 | $13,405.00 |
DisclosureSEC source: 0002064832-26-000129 · form4.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,014 Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 17:27 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 48,828 | $0.00 | $0.00 |
DisclosureSEC source: 0002064832-26-000054 · form4.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,014 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 17:45 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 49,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003217 · form4.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,186 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2026. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:20 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 51,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004306 · form4.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,611 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2025. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 17:45 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 65,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004881 · form4.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,591 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2024. Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 18:43 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 3,000 | $4.76 | $14,265.00 |
DisclosureSEC source: 0001062993-22-018040 · form4.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,854 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 19:01 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 20,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004806 · form4.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,854 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2023. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 18:23 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000064 · edgar.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,307 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on August 3, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 20:18 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 5,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000019 · edgar.xml · nonDerivative · entry 2 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,307 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. F3 · kind: The RSUs vest in full on February 16, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 20:18 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 6,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000019 · edgar.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,825 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. F2 · kind: The RSUs vest in full on April 1, 2022. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 17:05 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 6,943 | $3.25 | $22,564.75 |
DisclosureSEC source: 0001661181-20-000039 · edgar.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,507 Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:33 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A Common Stock | 18,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-20-000021 · edgar.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,564 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on April 1, 2021. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:31 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 5,000 | $4.20 | $21,000.00 |
DisclosureSEC source: 0001661181-19-000012 · edgar.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:26 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $7.04 | $0.00 |
DisclosureSEC source: 0001661181-18-000050 · edgar.xml · derivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-12-10 F1 · derivative.exercise_date: The option becomes exercisable in equal yearly installments over three years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.